Wash. Admin. Code § 296-823-180
Summary
Your responsibility:
To implement and enforce these additional rules in research laboratories and production facilities engaged in the culture, production, concentration, experimentation, and manipulation of HIV and HBV.
EXEMPTION: | This section does NOT apply to clinical or diagnostic laboratories engaged solely in the analysis of blood, tissues, or organs. |
Note: | Production and research facilities: Hepatitis C (HCV) is the virus involved in most cases of parenterally transmitted (blood-borne) non-A, non-B hepatitis in the United States. Most individuals who contract HCV become chronically infected (85%) and develop chronic hepatitis (70%). It is recommended that you also follow these requirements for HCV production and research facilities. |
| You must meet the requirements ... | in this section: |
| Prepare, review, and update a biosafety manual | WAC 296-823-18005 |
| Follow these special practices for the work area | WAC 296-823-18010 |
| Make sure these practices for contaminated material and waste are followed | WAC 296-823-18015 |
| Make sure these special practices for personal protective equipment (PPE) and other safeguards are followed | WAC 296-823-18020 |
| Protect vacuum lines | WAC 296-823-18025 |
| Use and handle hypodermic needles and syringes appropriately and safely | WAC 296-823-18030 |
| Handle all spills and accidents properly | WAC 296-823-18035 |
| Post signs | WAC 296-823-18040 |
| Provide additional training for facility employees | WAC 296-823-18045 |
| Furnish a sink for washing hands and a readily available eye wash facility | WAC 296-823-18050 |
| Make sure these additional criteria are followed for HIV and HBV production facilities | WAC 296-823-18055 |
Wash. Admin. Code § 296-823-180
Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. 04-12-070, § 296-823-180, filed 6/1/04, effective 9/1/04; 03-09-110, § 296-823-180, filed 4/22/03, effective 8/1/03.